期刊文献+

卵黄样黄斑营养不良基因三个新的点突变与散发性Best病表现型关系的分析 被引量:5

原文传递
导出
摘要 Best病又称Best卵黄样黄斑营养不良(BVMD),是一种不规则的常染色体显性遗传性疾病,也有一些散发病例;临床特征是幼年或青年时期双眼黄斑部视网膜出现卵黄状的脂质样沉积物,而视力一般不受影响。随着病情发展,卵黄样物质逐渐吸收,开始出现视力波动。患者常在40岁左右时常发展为视网膜色素上皮(RPE)萎缩,黄斑部视网膜纤维瘢痕形成,以及继发性脉络膜新生血管(CNV)形成和视网膜下出血,
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2009年第2期146-148,共3页 Chinese Journal of Ocular Fundus Diseases
  • 相关文献

参考文献15

  • 1Cross HE, Bard L. Electrooculography in the Best’s macular dystrophy. AmJ Ophthalmol, 1974, 77: 44-50.
  • 2Marquardt A, Stohr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Human Molecular Genetics, 1998, 7:1517 1525.
  • 3Stohr It, Marquardt A, Rivera A, et al. A gene map of the Best’s vitelliform macular dystrophy region in chromosome 11q12-q13.1. GenomeRes, 1998, 8:48-56.
  • 4Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet, 1998, 19: 241-247.
  • 5Godel V, Chaine G, Regenbogen L, et al. Best's vitelliform macular dystrophy. Acta Ophthalmol Suppl, 1986, 175: 1-31.
  • 6侯乒,陈伟民,陈伟奇,阎亦农,林顺潮,彭智培.Best病家系卵黄样黄斑营养不良基因突变分析[J].中华眼底病杂志,2006,22(2):86-89. 被引量:5
  • 7Sun H, Tsunenari T, Yau KW, et al. The vitelliform macular dystrophy protein defines a new family of chloroide channels. Natl Acad Sci USA, 2002, 99: 4008- 4013.
  • 8Marmorstein AD, Marmorstein I.Y, Rayborn M, et al. Bestrophin, the product of the Best vitelliforrn macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA, 2000, 97:12758-12763.
  • 9Tsunenari T, Sun H, Williams J, et al. Structure function analysis of the bestrophin family of anion channels. J Biol Chem, 2003, 278:41114-41125.
  • 10欧阳艳玲,张勇进,徐格致,江睿,陈倩,王玲.Best卵黄样黄斑营养不良一家系的临床表型特征和基因研究[J].中华眼科杂志,2008,44(4):321-326. 被引量:6

二级参考文献28

  • 1Arden GB, Barrada A, Kelsey JH. New clinical test of retinal function based on the standing potential of the eye. Br J Ophthalmol, 1962,46:449-467.
  • 2Guyer DR,Yannuzzi LA, Chang S, et al. Retina-vitreous-macula. Philadelphia: Saunders, 1999:989-1005.
  • 3Mohhr CW, Fine SL Long term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology, 1981,88:688-691.
  • 4Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein-functional implications. Human Genetics, 1999,104:383-389.
  • 5Pierro L, Tremolada G, Introini U, et al. Optical coherence tomography findings in adult-onset foveomacular vitelliform dystrophy. Am J Ophthalmol,2002 ,134 :675-680.
  • 6Pianta MJ, Aleman TS, Cideciyan AV, et al. In vivo micropathology of Best macular dystrophy with optical coherence tomography. Exp Eye Res,2003,76:203-211.
  • 7Graft C, Eriksson A, Forsman K, et al. Refined genetic localization of the Best disease gene in 11q13 and physical mapping of linked markers on radiation hybrids. Hum Genet, 1997,101:263-270.
  • 8Stohr H, Marquardt A, Rivers A, et al. A gene map of the Bests vitelliform macular dystrophy region in chromosome 11q12-q13.1. Genome Res, 1998,8:48-56.
  • 9Kramer F, Mohr N, Kellner U, et al. Ten novel mutations in VMD2 associated with Best maeular dystrophy (BMD). Hum Mutat, 2003,22:418-424.
  • 10White K, Marquardt A,Weber BH. VMD2 mutations in vitelliform macular dystrophy( Best's disease) and other maculopathies. Hum Mutat,2000,15:301-308.

共引文献7

同被引文献78

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部